Evidence for different 5-HT(1B/1D) receptors mediating vasoconstriction of equine digital arteries and veins

European Journal of Pharmacology

Volumn 355, Issue 2-3, 1998, Pages 175-187

  Bailey, Simon R ^a   Elliott, Jonathan ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

5 HT(1B 1D) receptor; Digital blood vessel, equine; Laminitis, equine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBAMOYLTRYPTAMINE; ANPIRTOLINE; BENEXTRAMINE; KETANSERIN; METERGOLINE; METITEPINE; PROPRANOLOL; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN; YOHIMBINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIGITAL ARTERY; HORSE; NONHUMAN; PRIORITY JOURNAL; VENOCONSTRICTION;

ANIMALS; ARTERIES; HINDLIMB; HORSES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; VASOCONSTRICTION; VEINS;

EID: 0031720579     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00520-2     Document Type: Article

References (36)

1. Allen Jr., D., Clark, E.S., Moore, J.N., 1990. Evaluation of equine digital Starling forces and hemodynamics in early laminitis. Am. J. Vet. Res. 51, 1930-1934.
2. Bailey, S.R., Elliott, J., 1996a. Characterisation of 5-HT receptors mediating vasoconstriction in equine digital arteries. Br. J. Pharmacol. 117, 269P.
3. 1-like receptors mediating vasoconstriction of isolated equine digital blood vessels: evidence for different receptor subtype. Br. J. Pharmacol. 119, 23P.
4. Bailey, S.R., Elliott, J., 1998. Plasma 5-hydroxytryptamine in equine constricts equine digital blood vessels Implications for the pathogenesis of acute laminitis. Equine Vet. J. 30, 124-130.
5. Barlow, R., 1983. The Use of Microcomputers for Biodata Handling. Elsevier, Amsterdam.
6. 1D-like receptors, and a comparison with grafted veins. Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 500-508.
7. Baxter, G.M., Laskey, R.E., Tackett, R.L., Moore, J.N., Allen, D., 1989. In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with laminitis. Am. J. Vet. Res. 50, 508-517.
8. Biondi, M.L., Marasini, B., Bianchi, E., 1988. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int. J. Cardiol. 19, 335-339.
9. 4 receptors. Br. J. Pharmacol. 107, 591-591.
10. 1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol. 112, 939-945.
11. Elliott, J., Bryant, C.E., Soydan, J., 1994. The role of nitric oxide in the responses of equine digital veins to vasodilator and vasoconstrictor agents. Equine Vet. J. 26, 378-384.
12. 1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 1-7.
13. Flaherty, J.T., Weisfeldt, M.L., 1988. Reperfusion injury. Free Radic. Biol. Metab. 5, 409-419.
14. Fozard, J.R., 1984. MDL 72222, a potent and highly selective anatagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 36-44.
15. 3H-PAT. Nature 305, 140-142.
16. Hood, D.M., Amoss, M.S., Grossenbaugh, D.A., 1990. Equine laminitis: a potential model for Raynaud's phenomenon. Angiology 41, 270-277.
17. Hood, D.M., Grosenbaugh, D.A., Mostafa, M.B., Morgan, S.J., Thomas, B.C., 1993. The role of vascular mechanisms in the development of acute equine laminitis. J. Vet. Int. Med. 7, 228-234.
18. 125I]iodocyanopindolol. Eur. J. Pharmacol. 118, 13-23.
19. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P.A., 1994. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
20. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94, 1123-1132.
21. Hunt, R.J., 1991. The pathophysiology of acute laminitis. Compend. Cont. Educ. 13, 1003-1010.
22. Kaumann, A.J., Saunders, L., Brown, A.M., Murray, K.J., Brown, M.J., 1990. A 5-hydroxytryptamine receptor in human atrium. Br. J. Pharmacol. 100, 879-885.
23. Leff, P., Martin, G.R., 1989. Quantification of the actions of 5-hydroxytryptamine receptor agonists and antagonists. In: Fozard, J.R. (Ed.), The Peripheral Actions of 5-hydroxytryptamine. Oxford Univ. Press, Oxford, pp. 26-44.
24. 7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol. 117, 926-930.
25. Martin, G.R., 1994. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther. 62, 283-324.
26. Martin, G.R., MacLennan, S.J., 1990. Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmeideberg's Arch. Pharmacol. 342, 111-119.
27. 1B receptors. Nature 360, 161-163.
28. Parsons, A.A., 1991. 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol. Sci. 12, 310-314.
29. 1D binding sites. Eur. J. Pharmacol. 163, 133-136.
30. 1D subtype. Br. J. Pharmacol. 102, 191-197.
31. Robinson, N.E., 1990. Digital blood flow, arteriovenous anastomoses and laminitis. Equine Vet. J. 22, 381-383.
32. 1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br. J. Pharmacol. 105, 732-738.
33. 1-like receptors mediating vasoconstriction of isolated equine digital veins. Br. J. Pharmacol. 114, 359P.
34. Ullmer, C., Schmuck, K., Lubbert, H., 1995. Expression of serotonin receptor mRNAs in blood vessels. FEBS Letters 370, 215-221.
35. 1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmeideberg's Arch. Pharmacol. 337, 595-601.
36. Weller, J., Soydan, J., Elliott, J., 1994. Characterisation of the receptors involved in the vasoconstrictor action of 5-hydroxytryptamine in equine digital vein. Br. J. Pharmacol. 112, 171P.